ETHERNIAAmbition, with intellectual discipline.
Ethernia exists to make the science of longer, healthier lives understandable without making it smaller—or more certain than it is.
Our starting point
Ageing is one of the largest unsolved problems in biology. Its consequences are personal, but the research spans molecular mechanisms, clinical medicine, computation and engineering. Readers need a way to connect these levels without confusing them.
Ethernia is an independent educational publication. It is not a clinic, a treatment provider or a supplement store. This edition contains seventeen intervention and measurement dossiers, a science guide, an evidence database and a research briefing.
The editorial standard
We assess a specific claim in a specific population. Each dossier separates human findings, animal experiments, mechanism, safety and evidence for longevity. A classification is an editorial interpretation of that claim—not a universal grade for a molecule.
Find the source
Prefer original research and trial records. Identify reviews and sponsor announcements.
Name the outcome
Distinguish primary from exploratory results, and biomarkers from clinical benefit.
Read the limits
Include null results, study population, duration, conflicts and uncertainty.
What the labels mean
Established and Promising refer to support for a stated outcome. Frontier marks an experimental clinical question; Speculative identifies a hypothesis beyond direct evidence. Unsupported means the specific claim is not justified by the available findings. None is a personal recommendation.
Read the full classification definitions.
Authorship and review
This edition was prepared with AI-assisted research and writing. It has not been independently reviewed by a named clinician or scientific advisory board. We do not display invented medical reviewer credentials. Publication and evidence-review dates are visible on dossiers.
Source selection prioritises relevance, study design and transparency. Commercial affiliations and sponsor-only announcements are identified where relevant. A company milestone is not treated as a peer-reviewed efficacy finding.
Corrections and updates
Substantive revisions should record what changed, why it changed and the evidence-review date. A new trial can alter a verdict; a new press release alone need not. Readers can prepare a source-backed correction through the contact and corrections page.
Commercial policy
This edition has no affiliate links, sponsored rankings, paid placements or product checkout. Any future commercial relationship should be disclosed on the affected page. Evidence classifications must remain independent of commercial interests.
What comes next
The architecture is built for more dossiers, deeper topic hubs and structured trial tracking. Intervention Compare and Trial Watch are now available. Ethernia Pulse personalizes research, while Ask Ethernia retrieves cited evidence. There is no personal health-data collection.